Restylane® Refyne, Restylane® Defyne, Restylane® Kysse and Restylane® Contour
FDA premarket approval P140029/S055 · decided 2025-09-26
Approval details
- PMA number
- P140029
- Supplement
- S055
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Restylane® Refyne, Restylane® Defyne, Restylane® Kysse and Restylane® Contour
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2025-09-04
- Decision date
- 2025-09-26
- Days to decision
- 22 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- approval for modifications to the Water for Injection (WFI) system
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.